‘‘(D) carry out any other necessary activi-
ties regarding the functioning of the Institute. 
‘‘(3) ADDITIONAL
BOARD
FUNCTIONS.—The 
Board may coordinate and collaborate with other en-
tities to conduct research, education, and outreach, 
and to modernize the sciences of developing, manu-
facturing, and evaluating the safety and effective-
ness of diagnostics, devices, biologics, and drugs. 
‘‘(4) TERMS AND VACANCIES.— 
‘‘(A) TERM.—The term of office of each 
member of the Board appointed under para-
graph (1)(C) shall be 4 years, except that the 
terms of offices for the initial appointed mem-
bers of the Board shall expire on a staggered 
basis as determined by the ex officio members. 
‘‘(B) VACANCY.—Any vacancy in the mem-
bership of the Board— 
‘‘(i) shall not affect the power of the 
remaining members to execute the duties 
of the Board; and 
‘‘(ii) shall be filled by appointment by 
the individuals described in clauses (i) 
through (v) of paragraph (1)(B) by major-
ity vote. 
VerDate Aug 31 2005 
23:40 Mar 22, 2007
Jkt 059200
PO 00000
Frm 00063
Fmt 6652
Sfmt 6201
E:\BILLS\H1561.IH
H1561
pwalker on PROD1PC71 with BILLS
‘‘(C) PARTIAL TERM.—If a member of the 
Board does not serve the full term applicable 
under subparagraph (A), the individual ap-
pointed under subparagraph (B) to fill the re-
sulting vacancy shall be appointed for the re-
mainder of the term of the predecessor of the 
individual. 
‘‘(D) SERVING PAST TERM.—A member of 
the Board may continue to serve after the expi-
ration of the term of the member until a suc-
cessor is appointed. 
‘‘(5) COMPENSATION.—Members of the Board 
may not receive compensation for service on the 
Board. Such members may be reimbursed for travel, 
subsistence, and other necessary expenses incurred 
in carrying out the duties of the Board, as set forth 
in the bylaws issued by the Board. 
‘‘(e) INCORPORATION.—The ex officio members of the 
Board shall serve as incorporators and shall take whatever 
actions necessary to incorporate the Institute. 
‘‘(f) NONPROFIT STATUS.—The Institute shall be 
considered to be a corporation under section 501(c) of the 
Internal Revenue Code of 1986, and shall be subject to 
the provisions of such section. 
‘‘(g) EXECUTIVE DIRECTOR.— 
VerDate Aug 31 2005 
23:40 Mar 22, 2007
Jkt 059200
PO 00000
Frm 00064
Fmt 6652
Sfmt 6201
E:\BILLS\H1561.IH
H1561
pwalker on PROD1PC71 with BILLS
‘‘(1) IN GENERAL.—The Board shall appoint an 
Executive Director who shall serve at the pleasure of 
the Board. The Executive Director shall be respon-
sible for the day-to-day operations of the Institute 
and shall have such specific duties and responsibil-
ities as the Board shall prescribe. 
‘‘(2) COMPENSATION.—The compensation of 
the Executive Director shall be fixed by the Board 
but shall not be greater than the compensation of 
the Commissioner of Food and Drugs. 
‘‘(h) ADMINISTRATIVE POWERS.—In carrying out 
this subchapter, the Board, acting through the Executive 
Director, may— 
‘‘(1) adopt, alter, and use a corporate seal, 
which shall be judicially noticed; 
‘‘(2) hire, promote, compensate, and discharge 
1 or more officers, employees, and agents, as may be 
necessary, and define their duties; 
‘‘(3) prescribe the manner in which— 
‘‘(A) real or personal property of the Insti-
tute is acquired, held, and transferred; 
‘‘(B) general operations of the Institute 
are to be conducted; and 
‘‘(C) the privileges granted to the Board 
by law are exercised and enjoyed; 
VerDate Aug 31 2005 
23:40 Mar 22, 2007
Jkt 059200
PO 00000
Frm 00065
Fmt 6652
Sfmt 6201
E:\BILLS\H1561.IH
H1561
pwalker on PROD1PC71 with BILLS